Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736).
Francolini G, Garlatti P, Di Cataldo V, Detti B, Loi M, Greto D, Simontacchi G, Morelli I, Burchini L, Allegra AG, Frosini G, Ganovelli M, Salvestrini V, Olmetto E, Visani L, Becherini C, Valzano M, Carnevale MG, Roghi M, Serni S, Mattioli C, Desideri I, Livi L. Francolini G, et al. Among authors: allegra ag. Cancers (Basel). 2023 Feb 3;15(3):992. doi: 10.3390/cancers15030992. Cancers (Basel). 2023. PMID: 36765948 Free PMC article.
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy.
Francolini G, Frosini G, Di Cataldo V, Detti B, Carnevale MG, Banini M, Peruzzi A, Salvestrini V, Visani L, Olmetto E, Becherini C, Allegra A, Burchini L, Scotti V, Mangoni M, Meattini I, Desideri I, Livi L. Francolini G, et al. J Geriatr Oncol. 2023 Jan;14(1):101411. doi: 10.1016/j.jgo.2022.11.010. Epub 2022 Dec 8. J Geriatr Oncol. 2023. PMID: 36496347
Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease.
Nicosia L, Allegra AG, Giaj-Levra N, Bayani R, Darzikolaee NM, Mazzola R, Pastorello E, Ravelli P, Ricchetti F, Rigo M, Ruggieri R, Gurrera D, Borgese RF, Gaito S, Minniti G, Navarria P, Scorsetti M, Alongi F. Nicosia L, et al. Among authors: allegra ag. Clin Transl Radiat Oncol. 2024 Jun 24;48:100811. doi: 10.1016/j.ctro.2024.100811. eCollection 2024 Sep. Clin Transl Radiat Oncol. 2024. PMID: 39036468 Free PMC article.
Reply to: Comment on "Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease".
Nicosia L, Allegra AG, Alongi F. Nicosia L, et al. Among authors: allegra ag. Clin Transl Radiat Oncol. 2024 Jul 27;48:100826. doi: 10.1016/j.ctro.2024.100826. eCollection 2024 Sep. Clin Transl Radiat Oncol. 2024. PMID: 39184999 Free PMC article. No abstract available.
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).
Francolini G, Allegra AG, Detti B, Di Cataldo V, Caini S, Bruni A, Ingrosso G, D'Angelillo RM, Alitto AR, Augugliaro M, Triggiani L, Parisi S, Facchini G, Banini M, Simontacchi G, Desideri I, Meattini I, Valicenti RK, Livi L; ARTO Working Group members. Francolini G, et al. Among authors: allegra ag. J Clin Oncol. 2023 Dec 20;41(36):5561-5568. doi: 10.1200/JCO.23.00985. Epub 2023 Sep 21. J Clin Oncol. 2023. PMID: 37733977 Clinical Trial.
Curriculum mapping of accredited pharmacy programs in the United States.
Talasaz AH, Donohoe KL, Van Tassell B; VCU Curriculum Investigators; Truong A, Shaunak A, Wayne A, Brenner A, Cherian B, Long B, Clemons B, Cason C, Hoang CC, Tran C, Dent D, Quinn E, Allegra AG, Price G, Sharp H, Nguyen H, Gomez J, Hodge J, Lai J, Everett J, Hunt J, Zhang J, Zhang J, Hsu J, Bowles K, Rowe K, Loch K, Han K, Reid K, So L, Noble M, Puryear M, Dance M, Bland M, LaPorte M, Lowe N, DiStefano N, Crawford P, Spence R, Fleku S, Henderson S, Viramgama S, Lee S, Yang S, Vickhouse S, Saunders S, Roussel S, Cuffee T, Huynh T, Olajide T, Yousufzai Y. Talasaz AH, et al. Among authors: allegra ag. Curr Pharm Teach Learn. 2023 Jul;15(7):661-665. doi: 10.1016/j.cptl.2023.06.017. Epub 2023 Jun 29. Curr Pharm Teach Learn. 2023. PMID: 37391352
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience.
Francolini G, Campi R, Di Cataldo V, Detti B, Loi M, Triggiani L, La Mattina S, Borghetti P, Magrini SM, Nicosia L, Alongi F, Ghirardelli P, Vavassori V, Allegra AG, Aquilano M, Scoccimarro E, Peruzzi A, Pastina P, Visani L, Desideri I, Serni S, Meattini I, Livi L. Francolini G, et al. Among authors: allegra ag. Clin Transl Oncol. 2022 Oct;24(10):2039-2043. doi: 10.1007/s12094-022-02844-5. Epub 2022 Jun 23. Clin Transl Oncol. 2022. PMID: 35739349 Free PMC article.
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275).
Francolini G, Loi M, Ciccone LP, Detti B, Di Cataldo V, Pinzani P, Salvianti F, Salvatore G, Sottili M, Santini C, Frosini G, Visani L, Burchini L, Mattioli C, Allegra AG, Valzano M, Cerbai C, Aquilano M, Salvestrini V, Desideri I, Mangoni M, Meattini I, Livi L. Francolini G, et al. Among authors: allegra ag. Med Oncol. 2022 Jun 10;39(8):119. doi: 10.1007/s12032-022-01756-2. Med Oncol. 2022. PMID: 35687207
39 results